We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TIME LIMITS MAR FDA's DRAFT GUIDANCE ON cGMP DISPUTE RESOLUTION
TIME LIMITS MAR FDA's DRAFT GUIDANCE ON cGMP DISPUTE RESOLUTION
February 13, 2004
PhRMA believes time limitations defined in an FDA draft guidance on dispute resolution (DR) would place manufacturers at a disadvantage when using the system or result in dispute resolution requests that are incomplete.